Back to results
US 7,741,374 B1Granted
Methods of use of fenofibric acid
AssigneeMutual Pharmaceutical Company, Inc.
InventorsKristin Anne Arnold, Hengsheng Feng
Life of this patent
Estimating the term…
Abstract
Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. Dosage forms include, for example, immediate-release dosage forms.
Claims2
A method of treating a patient in need of treatment for an indication involving increased cholesterol and/or lipid levels, comprising
- administering to the patient an immediate-release 105 mg fenofibric acid dosage form without regard to meals, wherein immediate release is release of 90% or greater of the fenofibric acid in the dosage form at 2 hours measured in a single pH buffer.
A method of treating a patient in need of treatment for mixed dyslipidemia, comprising
- administering to the patient an immediate-release 105 mg fenofibric acid dosage form without regard to meals, wherein immediate release is release of 90% or greater of the fenofibric acid in the dosage form at 2 hours measured in a single pH buffer.
Dependencies are inferred from the claim text.